• 结论癌肿姑息切除联合肝动脉置管埋泵化疗有助于提高中晚期肝癌患者的生存时间和生命质量。

    Conclusions Palliative resection of liver cancer and implanted with a drug delivery system can improve survival duration and life quality of patients with advanced HCC.

    youdao

  • 目的探讨晚期肝癌患者的临终护理特点。

    Objective To explore the features of hospice care of patients with advanced stage of liver cancer.

    youdao

  • 目的:探讨安替可胶囊对中晚期肝癌的临床疗效。

    Objective: To observe the clinical effect of Antike capsule treating hepatocellular carcinoma of middle-later period.

    youdao

  • 肝动脉栓塞微球是用于治疗中晚期肝癌的新剂型。

    The microsphere for hepatic arterial embolization is a newdosage form for treatment of non-resectable liver cancer.

    youdao

  • 肝动脉栓塞微球是用于治疗中晚期肝癌的新剂型。

    The microsphere for hepatic arterial embolization is a new dosage form in the treatment of non-resectable liver cancer.

    youdao

  • 目的:探讨中、晚期肝癌变异、寄生性供血的产生机理。

    Purpose: Study the mechanism of variation and parasitic blood supply in advanced hepatic cancers.

    youdao

  • 目的:观察中医综合治疗方案治疗原发性中晚期肝癌的疗效。

    Objective: to observe the effects of complex treatment with traditional Chinese medicine on advanced primary hepatocarcinoma.

    youdao

  • 目的总结晚期肝癌并肝包膜下出血或肝破裂出血的护理要点。

    Objective To summarize the nursing in patients with advanced liver carcinoma complicating liver capsule bleeding and liver bleeding.

    youdao

  • 结论:复方苦参注射液联合复方斑蝥胶囊治疗晚期肝癌疗效较好。

    Conclusion: Complex Prescription Inj. of Kuhseng(Inj. Yan-shu) combined with Complex Prescription Capsule of Cantharides has good and reliable effect on hepatoma in advanced stage.

    youdao

  • 目的观察肝动脉化疗栓塞联合无水乙醇注射治疗中晚期肝癌的疗效。

    Objective To observe the clinical therapeutic effect of transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) in moderate or advanced liver cancer.

    youdao

  • 目的评价姑息切除联合肝动脉置管埋泵在中晚期肝癌治疗中的作用。

    Objective to evaluate the effect of palliative resection and implanted with a drug delivery system of advanced primary hepatocellular carcinoma (PHCC).

    youdao

  • 目的:探讨3 2磷玻璃微球内放射栓塞治疗中晚期肝癌的效果。

    Objective:To determine the therapeutic effects of hepatic radioembolization with phosphorus 32 glass microsphere( 32 P GMS) in the treatment of hepatocellular carcinoma(HCC).

    youdao

  • 目的:探讨健脾消积口服液对改善晚期肝癌患者生存质量的临床疗效。

    Objective: To study clinical therapeutic effect of Jianpi Xiaoji Oral Liquid on life quality in patients of late liver cancer.

    youdao

  • 目的探讨超声引导下局部治疗结合门静脉化疗在中晚期肝癌中的应用。

    Objective To investigate the application of local treatment combining with chemotherapy via portal vein guided by US in advanced hepatic cancer.

    youdao

  • 对于已进行了手术的晚期肝癌患者,手术会影响索拉非尼的安全性和疗效吗?

    For those patients with advanced HCC, who have had surgical resection, with the surgery impact the safety and efficacy of sorafenib?

    youdao

  • 探索介入化疗、局部注射TIL、瘤内无水酒精注射综合治疗晚期肝癌的疗效。

    To probe into curative effect of comprehensively treating hepatocellular carcinoma by interventional chemotherapy, locally injecting TIL and injecting absolute alcohol into tumor.

    youdao

  • 目的研究肝动脉化疗栓塞基础上经皮经肝门静脉灌注化疗治疗晚期肝癌的疗效。

    Objective To study the effect of transcatheter chemoembolization(TACE) plus percutaneous transhepatic portochemotherapy(PTP)for the treatment of primary liver cancer(PLC).

    youdao

  • 目的:观察苦参碱注射液配合TACE术治疗晚期肝癌的疗效及实验室指标的变化。

    Objective:Observe the therapeutic effect and lab index changes of metaphase late liver cancer treated by matrine injection together with TACE operation.

    youdao

  • 目的经肝动脉介入性灌注与热灌注化疗治疗中晚期肝癌,观察对比病灶大小、生存期。

    Objective To observe and compare the volumes and survival periods of tumors in the patients with advanced liver cancer after treatments of transhepatic arterial infusion and heat infusion.

    youdao

  • 结果说明,冷冻治疗中晚期肝癌有一定临床疗效,目前看来可以缓解症状,延长生命。

    This result suggested that the frozen treatment for primary hepatic carcinoma in middle and advanced stage has definite palliative effect to relieve the symptoms and to prolong the live span.

    youdao

  • 目的探讨经肝动脉化疗栓塞(TACE)结合二期手术切除治疗原发性中晚期肝癌的价值。

    Objective to evaluate the value of transhepatic arterial chemoembolization (TACE) combined with secondary hepatectomy for advanced primary liver carcinoma.

    youdao

  • 目的:研究中药96 0合剂内服配合肝动脉栓塞化疗(TACE)治疗晚期肝癌的临床疗效。

    Objective: To evaluate the clinical effectiveness of herbal medication 960 mixture combined with transcatheter arterial chemoembolization (TACE) in the treatment of advanced liver cancer.

    youdao

  • 目的探讨合并肝动脉-门静脉瘘的晚期肝癌患者行肝动脉-门静脉瘘介入封堵治疗的临床疗效。

    Objective To investigate the efficacy of interventional obstructive therapy for patients with liver cancer complicated with intrahepatic arteriovenous fistula.

    youdao

  • 以LCID 20裸鼠人肝癌转移模型为材料,观察丹参对早期和晚期肝癌切除术后转移复发的影响。

    LCI D20 human liver cancer metastasis model, after hepatectomy, was used to observe the effect of RSM on recurrence and metastasis of liver carcinoma in nude mice.

    youdao

  • 国际肝病:最近有研究报道索拉非尼用于治疗晚期肝癌,主要是SHARP临床试验和亚太地区的试验。

    HEPATOLOGY DIGEST: Recently there were reported studies on the efficacy of sorafenib in treating patients with advanced hepatocellular carcinoma mainly the SHARP trial and the Asia-Pacific study.

    youdao

  • 介入治疗是晚期肝癌的主要治疗手段,术后随访中及时、准确评价疗效是手术取得良好疗效的重要保证。

    Interventional therapy is the main treatment of advanced liver cancer. Timely following-up and accurate evaluation after interventional therapy is of important value for good clinical efficacy.

    youdao

  • 索拉非尼改善了患者生存期,虽然不是很明显,但却是肝癌治疗的一大进步,同时也激发了晚期肝癌一线治疗药物的开发。

    The improvement insurvival facilitated by sorafenib, even though modest, was a major advance for the treatment of HCC, and stimulated drug development in first line treatment of HCC.

    youdao

  • 索拉非尼改善了患者生存期,虽然不是很明显,但却是肝癌治疗的一大进步,同时也激发了晚期肝癌一线治疗药物的开发。

    The improvement insurvival facilitated by sorafenib, even though modest, was a major advance for the treatment of HCC, and stimulated drug development in first line treatment of HCC.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定